These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3009012)
1. Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine. Griffiths JD; Stark RJ; Ding JC; Cooper IA Cancer Treat Rep; 1986 Apr; 70(4):519-21. PubMed ID: 3009012 [TBL] [Abstract][Full Text] [Related]
2. Investigation of the additive potential of teniposide and vincristine in non-Hodgkin's lymphoma. Australian and New Zealand Lymphoma Group. Cancer Treat Rep; 1986 Aug; 70(8):985-90. PubMed ID: 2873890 [TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiological studies in vincristine induced neuropathy. Pal PK Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201 [TBL] [Abstract][Full Text] [Related]
4. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma. Cancer Treat Rep; 1982 Jan; 66(1):49-55. PubMed ID: 7053265 [TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity and efficacy of combined vinca alkaloids in breast cancer. Stewart DJ; Maroun JA; Lefebvre B; Heringer R Cancer Treat Rep; 1986 May; 70(5):571-3. PubMed ID: 3011256 [TBL] [Abstract][Full Text] [Related]
8. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662 [TBL] [Abstract][Full Text] [Related]
9. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399 [TBL] [Abstract][Full Text] [Related]
10. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia. Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067 [No Abstract] [Full Text] [Related]
11. [A case of non-Hodgkin's lymphoma presenting optic neuropathy induced by vincristine]. Hashimoto K; Akagawa S; Takashimizu I; Tamura A; Kubota T; Murota N; Tanoue M; Momoi H; Mitsunaga K Nihon Naika Gakkai Zasshi; 1984 Aug; 73(8):1217-21. PubMed ID: 6512355 [No Abstract] [Full Text] [Related]
12. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease]. Uno S; Katayama K; Dobashi N; Hirano A; Ogihara A; Yamazaki H; Usui N; Kobayashi T; Inoue K; Kuraishi Y Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891 [TBL] [Abstract][Full Text] [Related]
13. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia. Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069 [TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Chaudhry V; Rowinsky EK; Sartorius SE; Donehower RC; Cornblath DR Ann Neurol; 1994 Mar; 35(3):304-11. PubMed ID: 7907208 [TBL] [Abstract][Full Text] [Related]
15. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814 [TBL] [Abstract][Full Text] [Related]
16. Experience with vincristine--associated neurotoxicity. Othieno-Abinya NA; Nyabola LO East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264 [TBL] [Abstract][Full Text] [Related]
17. Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma. Wanschitz J; Dichtl W; Budka H; Löscher WN; Boesch S Muscle Nerve; 2006 Oct; 34(4):494-8. PubMed ID: 16671108 [TBL] [Abstract][Full Text] [Related]
18. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma]. Sampi K; Honda T; Hattori M; Takayama S Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677 [TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced refractory lymphoma with teniposide and lomustine. Grossberg H; Opfell R; Glick J; Bakemeier R; Schnetzer G; Muggia F Cancer Treat Rep; 1987 Feb; 71(2):215-6. PubMed ID: 3802119 [No Abstract] [Full Text] [Related]
20. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study. Davidson KL; Devaney MB; Tighe JE; Rogers SY; Dunlop DJ; Mackie MJ; Thomas RV; Johnson PR; Haematologica; 2003 Dec; 88(12):1366-71. PubMed ID: 14687989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]